绝经-话题@MedSci

#绝经#

373篇内容 | 6424人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1257211, encodeId=942c125e211fd, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, objectTitle=哌柏西利联合方案为绝经前HR+晚期乳腺癌患者带来新希望！, objectType=article, longId=168153, objectId=1b2d1681532a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b2d1681532a, replyNumber=0, likeNumber=69, createdTime=2019-06-13, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b2d1681532a, moduleTitle=哌柏西利联合方案为绝经前HR+晚期乳腺癌患者带来新希望！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b2d1681532a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257210, encodeId=8e49125e210d7, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, objectTitle=HR+晚期乳腺癌内分泌治疗优先再添力证！Young-PEARL为绝经前HR+晚期乳腺癌患者带来新希望, objectType=article, longId=167917, objectId=760c16e91728, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=760c16e91728, replyNumber=0, likeNumber=63, createdTime=2019-06-11, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=760c16e91728, moduleTitle=HR+晚期乳腺癌内分泌治疗优先再添力证！Young-PEARL为绝经前HR+晚期乳腺癌患者带来新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=760c16e91728)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257209, encodeId=6132125e209d8, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, objectTitle=NEJM重磅！FDA连环惊喜，新批准的两种靶向药使绝经前后乳腺癌患者均受益！, objectType=article, longId=167722, objectId=27fa16e72219, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27fa16e72219, replyNumber=0, likeNumber=95, createdTime=2019-06-06, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27fa16e72219, moduleTitle=NEJM重磅！FDA连环惊喜，新批准的两种靶向药使绝经前后乳腺癌患者均受益！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27fa16e72219)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257208, encodeId=76aa125e208fd, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, objectTitle=仑伐替尼联合来曲唑在绝经后HR+局部晚期/转移性乳腺癌中的探索, objectType=article, longId=166861, objectId=f28a1668612c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f28a1668612c, replyNumber=0, likeNumber=65, createdTime=2019-05-28, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f28a1668612c, moduleTitle=仑伐替尼联合来曲唑在绝经后HR+局部晚期/转移性乳腺癌中的探索, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f28a1668612c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257207, encodeId=918f125e20706, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, objectTitle=绝经女性，要不要做激素替代？, objectType=article, longId=166469, objectId=70f8166469ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70f8166469ae, replyNumber=0, likeNumber=88, createdTime=2019-05-22, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70f8166469ae, moduleTitle=绝经女性，要不要做激素替代？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70f8166469ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257206, encodeId=a2c2125e206f6, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, objectTitle=JCLA：绝经后梅尼埃病患者听觉前庭功能与雌激素水平的关系, objectType=article, longId=166240, objectId=c15816624076, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c15816624076, replyNumber=0, likeNumber=83, createdTime=2019-05-18, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c15816624076, moduleTitle=JCLA：绝经后梅尼埃病患者听觉前庭功能与雌激素水平的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c15816624076)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257205, encodeId=2589125e2050f, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, objectTitle=BioSyent宣布加拿大卫生部批准替勃龙，用于治疗绝经后妇女的血管舒缩, objectType=article, longId=166109, objectId=00b81661090d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00b81661090d, replyNumber=0, likeNumber=68, createdTime=2019-05-16, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00b81661090d, moduleTitle=BioSyent宣布加拿大卫生部批准替勃龙，用于治疗绝经后妇女的血管舒缩, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00b81661090d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257204, encodeId=3e5d125e20415, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, objectTitle=围绝经期综合征激素替代治疗致溢乳1例, objectType=article, longId=165086, objectId=bf4316508656, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf4316508656, replyNumber=0, likeNumber=62, createdTime=2019-04-29, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf4316508656, moduleTitle=围绝经期综合征激素替代治疗致溢乳1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf4316508656)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257203, encodeId=cca3125e203fd, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, objectTitle=2019 TES临床实践指南：女性绝经后骨质疏松症的药物治疗, objectType=article, longId=164262, objectId=5e1516426299, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e1516426299, replyNumber=0, likeNumber=56, createdTime=2019-04-15, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e1516426299, moduleTitle=2019 TES临床实践指南：女性绝经后骨质疏松症的药物治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e1516426299)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257202, encodeId=0665125e20273, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, objectTitle=BMJ：女性绝经后使用激素治疗阿尔兹海默症的风险分析, objectType=article, longId=164238, objectId=d7171642389c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7171642389c, replyNumber=0, likeNumber=50, createdTime=2019-04-15, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7171642389c, moduleTitle=BMJ：女性绝经后使用激素治疗阿尔兹海默症的风险分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7171642389c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257201, encodeId=7fcd125e201a4, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, objectTitle=安进/优时比的抗骨硬化蛋白单抗romosozumab，获FDA批准治疗绝经后妇女的骨质疏松症, objectType=article, longId=164049, objectId=df2216404974, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df2216404974, replyNumber=0, likeNumber=57, createdTime=2019-04-12, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df2216404974, moduleTitle=安进/优时比的抗骨硬化蛋白单抗romosozumab，获FDA批准治疗绝经后妇女的骨质疏松症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df2216404974)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257200, encodeId=3103125e20063, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, objectTitle=JCEM：肥胖对女性自然绝经年龄与2型糖尿病风险之间关联的影响, objectType=article, longId=163424, objectId=01ff16342447, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01ff16342447, replyNumber=0, likeNumber=95, createdTime=2019-04-03, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01ff16342447, moduleTitle=JCEM：肥胖对女性自然绝经年龄与2型糖尿病风险之间关联的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01ff16342447)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257199, encodeId=1759125e19941, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, objectTitle=针对绝经后骨质疏松症治疗的新指南, objectType=article, longId=163093, objectId=547c163093e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=547c163093e3, replyNumber=0, likeNumber=75, createdTime=2019-03-29, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=547c163093e3, moduleTitle=针对绝经后骨质疏松症治疗的新指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=547c163093e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257198, encodeId=cfa6125e1987e, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, objectTitle=Gastroenterology：艾美拉唑和右兰索拉唑不会影响健康绝经后女性骨稳态, objectType=article, longId=162291, objectId=e9e416229189, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9e416229189, replyNumber=0, likeNumber=57, createdTime=2019-03-15, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9e416229189, moduleTitle=Gastroenterology：艾美拉唑和右兰索拉唑不会影响健康绝经后女性骨稳态, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9e416229189)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257197, encodeId=30c6125e19746, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, objectTitle=BMJ：绝经后激素治疗与阿尔茨海默病的风险, objectType=article, longId=161877, objectId=2c331618e73c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c331618e73c, replyNumber=0, likeNumber=42, createdTime=2019-03-09, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c331618e73c, moduleTitle=BMJ：绝经后激素治疗与阿尔茨海默病的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c331618e73c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257196, encodeId=c60e125e196bd, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, objectTitle=JAHA：绝经后妇女25-羟基维生素D和甲状旁腺激素水平的种族差异和心血管疾病风险, objectType=article, longId=160382, objectId=3c4d16038232, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c4d16038232, replyNumber=0, likeNumber=76, createdTime=2019-02-20, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c4d16038232, moduleTitle=JAHA：绝经后妇女25-羟基维生素D和甲状旁腺激素水平的种族差异和心血管疾病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c4d16038232)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257195, encodeId=2a05125e19581, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, objectTitle=J Clin Endocrinol Metab：特立帕肽治疗对骨质疏松症绝经后妇女循环骨膜素的影响及其与骨形成和骨密度调节因子的关系, objectType=article, longId=160252, objectId=59fc160252db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59fc160252db, replyNumber=0, likeNumber=75, createdTime=2019-02-18, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59fc160252db, moduleTitle=J Clin Endocrinol Metab：特立帕肽治疗对骨质疏松症绝经后妇女循环骨膜素的影响及其与骨形成和骨密度调节因子的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59fc160252db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257194, encodeId=fe52125e194bf, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, objectTitle=2018 ACR适宜性标准：绝经后亚急性或慢性盆腔疼痛, objectType=article, longId=159386, objectId=7702159386d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7702159386d7, replyNumber=0, likeNumber=14, createdTime=2019-02-03, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7702159386d7, moduleTitle=2018 ACR适宜性标准：绝经后亚急性或慢性盆腔疼痛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7702159386d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257193, encodeId=b328125e19344, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, objectTitle=Med Sci Monit：间歇性甲状旁腺激素1-34给药对绝经后骨质疏松妇女循环间充质干细胞的影响, objectType=article, longId=158997, objectId=243e15899e2b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=243e15899e2b, replyNumber=0, likeNumber=71, createdTime=2019-01-28, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=243e15899e2b, moduleTitle=Med Sci Monit：间歇性甲状旁腺激素1-34给药对绝经后骨质疏松妇女循环间充质干细胞的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=243e15899e2b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257192, encodeId=49dd125e19213, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, objectTitle=Biochem Biophys Res Commun：Let-7a-5p抑制绝经后骨质疏松症小鼠的骨髓间充质干细胞成骨, objectType=article, longId=158930, objectId=3c3715893033, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c3715893033, replyNumber=0, likeNumber=54, createdTime=2019-01-27, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c3715893033, moduleTitle=Biochem Biophys Res Commun：Let-7a-5p抑制绝经后骨质疏松症小鼠的骨髓间充质干细胞成骨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c3715893033)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

绝经

2020-05-29

yeye5224612 (审核中...)

前往app查看评论内容

#绝经#

哌柏西利联合方案为绝经前HR+晚期乳腺癌患者带来新希望！

2019-06-13

yeye5224612 (审核中...)

前往app查看评论内容

#绝经#

HR+晚期乳腺癌内分泌治疗优先再添力证！Young-PEARL为绝经前HR+晚期乳腺癌患者带来新希望

2019-06-11

yeye5224612 (审核中...)

前往app查看评论内容

#绝经#

NEJM重磅！FDA连环惊喜，新批准的两种靶向药使绝经前后乳腺癌患者均受益！

2019-06-06

yeye5224612 (审核中...)

前往app查看评论内容

#绝经#

仑伐替尼联合来曲唑在绝经后HR+局部晚期/转移性乳腺癌中的探索

2019-05-28

yeye5224612 (审核中...)

前往app查看评论内容

#绝经#

绝经女性，要不要做激素替代？

2019-05-22

yeye5224612 (审核中...)

前往app查看评论内容

#绝经#

JCLA：绝经后梅尼埃病患者听觉前庭功能与雌激素水平的关系

2019-05-18

yeye5224612 (审核中...)

前往app查看评论内容

#绝经#

BioSyent宣布加拿大卫生部批准替勃龙，用于治疗绝经后妇女的血管舒缩

2019-05-16

yeye5224612 (审核中...)

前往app查看评论内容

#绝经#

围绝经期综合征激素替代治疗致溢乳1例

2019-04-29

yeye5224612 (审核中...)

前往app查看评论内容

#绝经#

2019 TES临床实践指南：女性绝经后骨质疏松症的药物治疗

2019-04-15

yeye5224612 (审核中...)

前往app查看评论内容

#绝经#

BMJ：女性绝经后使用激素治疗阿尔兹海默症的风险分析

2019-04-15

yeye5224612 (审核中...)

前往app查看评论内容

#绝经#

安进/优时比的抗骨硬化蛋白单抗romosozumab，获FDA批准治疗绝经后妇女的骨质疏松症

2019-04-12

yeye5224612 (审核中...)

前往app查看评论内容

#绝经#

JCEM：肥胖对女性自然绝经年龄与2型糖尿病风险之间关联的影响

2019-04-03

yeye5224612 (审核中...)

前往app查看评论内容

#绝经#

针对绝经后骨质疏松症治疗的新指南

2019-03-29

yeye5224612 (审核中...)

前往app查看评论内容

#绝经#

Gastroenterology：艾美拉唑和右兰索拉唑不会影响健康绝经后女性骨稳态

2019-03-15

yeye5224612 (审核中...)

前往app查看评论内容

#绝经#

BMJ：绝经后激素治疗与阿尔茨海默病的风险

2019-03-09

yeye5224612 (审核中...)

前往app查看评论内容

#绝经#

JAHA：绝经后妇女25-羟基维生素D和甲状旁腺激素水平的种族差异和心血管疾病风险

2019-02-20

yeye5224612 (审核中...)

前往app查看评论内容

#绝经#

J Clin Endocrinol Metab：特立帕肽治疗对骨质疏松症绝经后妇女循环骨膜素的影响及其与骨形成和骨密度调节因子的关系

2019-02-18

yeye5224612 (审核中...)

前往app查看评论内容

#绝经#

2018 ACR适宜性标准：绝经后亚急性或慢性盆腔疼痛

2019-02-03

yeye5224612 (审核中...)

前往app查看评论内容

#绝经#

Med Sci Monit：间歇性甲状旁腺激素1-34给药对绝经后骨质疏松妇女循环间充质干细胞的影响

2019-01-28

yeye5224612 (审核中...)

前往app查看评论内容

#绝经#

Biochem Biophys Res Commun：Let-7a-5p抑制绝经后骨质疏松症小鼠的骨髓间充质干细胞成骨

2019-01-27

科室
- - 订阅+
  - 更多科室
工具
服务